Abstract:Summary Background IgG4-related disease is a multiorgan fibroinflammatory disease considered to have an autoimmune origin. Case series describing individual organ involvement have suggested differences in phenotypic expression between males and females. We aimed to characterise differences in IgG4-related disease manifestations between male and female patients in a large single-centre cohort. Methods In this retrospective, single-centre cohort study, patients were recruited from the Massachusetts General Hospital Rheumatology Clinic (Boston, MA, USA) and classified according to the American College of Rheumatology–European Alliance of Associations for Rheumatology (ACR–EULAR) classification criteria. Only patients satisfying the ACR–EULAR classification criteria were included in the study. Data on age at diagnosis, organ involvement at baseline, treatment status, and pre-treatment laboratory values were collected. Circulating plasmablasts and B-cell subsets were quantitated by flow cytometry. Active disease was defined by an IgG4-related disease Responder Index score of more than 0. Laboratory values were analysed for patients who were untreated at baseline and had active IgG4-related disease. The main outcomes were assessed in all participants with available data. Findings Of the 564 participants enrolled in the Massachusetts General Hospital Rheumatology Clinic IgG4-related disease Registry, 328 fulfilled ACR–EULAR classification criteria and were included between January, 2008, and May, 2023. There was a strong male predominance (male:female ratio 2·2:1) with 226 (69%) males and 102 (31%) females, which contrasted markedly with our general rheumatology clinic population (0·4:1; p<0·001). The male predominance increased with each decade of life starting at age 40 years. On average, male patients were 5·5 years older at diagnosis than female patients (63·7 years vs 58·2 years; p=0·0031). We observed male patients to have higher ACR–EULAR classification criteria scores at baseline with a median score of 35·0 (IQR 28·0–46·0), compared with 29·5 (25·0–39·0) for females (p=0·0010). T he proportion of male patients with pancreatic and renal involvement was almost double the proportion observed in female patients (50% of the male patients had pancreatic involvement, compared with about 26% of the female patients; p<0·0001). Male patients were more likely to have serological abnormalities at baseline. The distribution of IgG4 values differed significantly between male an female sexes, favouring higher values in males. We found that male patients with IgG4-related disease were more likely to have active B-cell responses in the blood as defined by plasmablast expansions. Interpretation IgG4-related disease is unusual among autoimmune diseases in that it is more likely to affect males than females and to present with a striking sex-dependent organ distribution and degree of B-cell response. These findings highlight important variation between IgG4-related disease and other conditions generally believed to have an autoimmune basis. Most autoimmune diseases, by contrast to IgG4-related disease, demonstrate pronounced predilections for affecting females more frequently than males. Hypotheses surrounding the cause and pathophysiology of this condition need to consider this unusual sex distribution among patients with IgG4-related disease. Funding National Institutes of Health, National Institute of Allergy and Infectious Diseases, Rheumatology Research Foundation, and the National Institute of Arthritis and Musculoskeletal and Skin Diseases.

Are Gender Differences Important for Autoimmune Liver Diseases?

Hepatic immune regulation and sex disparities

Mechanisms underlying sex differences in autoimmunity

The connective tissue diseases and the overall influence of gender

The Influence of Sex Hormones in Liver Function and Disease

Sex and regional disparities in incidence of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis

Unmet Challenges in Immune-Mediated Hepatobiliary Diseases

Impact of sex disparities on the clinical manifestations in patients with systemic lupus erythematosus: A systematic review and meta-analysis

Sex disparities in clinical characteristics and prognosis of immunoglobulin G4-related disease: a prospective study of 403 patients

Sex Hormone-Dependent Physiology and Diseases of Liver

Sex Differences in Lipid Metabolism: Implications for Systemic Lupus Erythematosus and Cardiovascular Disease Risk

Gender disparity between first and senior authors on liver cancer research in the top journals of Gastroenterology and Hepatology

Autoimmune Liver Diseases in Children

Sex as a predictor of clinical phenotype and determinant of immune response in IgG4-related disease: a retrospective study of patients fulfilling the American College of Rheumatology–European League Against Rheumatism classification criteria

Extrahepatic Autoimmune Conditions Associated with Primary Biliary Cirrhosis

The future of autoimmune liver diseases – Understanding pathogenesis and improving morbidity and mortality

Gender Differences and Immunotherapy Outcome in Advanced Lung Cancer

The impact of hormones in autoimmune cutaneous diseases

Analysis of Prognosis and Coexistence with Other Autoimmune Diseases in 232 Patients with Autoimmune Liver Disease

Sex Dimorphism in Pulmonary Arterial Hypertension Associated With Autoimmune Diseases

The Coexistence of Sjögren's Syndrome and Primary Biliary Cirrhosis: A Comprehensive Review